Key Points
- ASP Isotopes COO Robert Ainscow sold 8,438 shares at an average price of $4.29, generating $36,199.02. The sale covered tax-withholding obligations, reducing his stake by 0.37% to 2.25 million shares.
- ASPI shares were down 7.8%, opening at $3.31 and trading near their 12-month low of $3.30. The company reported a quarterly loss of $0.28 per share, missing estimates, although revenue of $5.12 million exceeded expectations.
- Analyst sentiment remains mixed, with a consensus rating of Hold and a $13.00 target price; institutional investors own 16.8% of the company.
ASP Isotopes Inc. (NASDAQ:ASPI - Get Free Report) COO Robert Ainscow sold 8,438 shares of the company's stock in a transaction dated Tuesday, September 8th. The shares were sold at an average price of $4.29, for a total transaction of $36,199.02. Following the completion of the transaction, the chief operating officer owned 2,248,441 shares in the company, valued at approximately $9,645,811.89. This trade represents a 0.37% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Robert Ainscow also recently made the following trade(s):
- On Wednesday, September 2nd, Robert Ainscow sold 25,000 shares of ASP Isotopes stock. The shares were sold at an average price of $3.90, for a total transaction of $97,500.00.
ASP Isotopes Trading Down 7.8%
Shares of ASPI stock opened at $3.31 on Friday. The firm has a 50 day moving average price of $4.16 and a two-hundred day moving average price of $5.15. The company has a quick ratio of 3.85, a current ratio of 3.87 and a debt-to-equity ratio of 0.76. The company has a market capitalization of $507.46 million, a PE ratio of -2.51 and a beta of 3.59. ASP Isotopes Inc. has a 12-month low of $3.30 and a 12-month high of $14.49.
ASP Isotopes (NASDAQ:ASPI - Get Free Report) last issued its quarterly earnings data on Friday, August 14th. The company reported ($0.28) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.17) by ($0.11). ASP Isotopes had a negative return on equity of 64.99% and a negative net margin of 427.98%.The firm had revenue of $5.12 million for the quarter, compared to the consensus estimate of $4.47 million.
Analyst Upgrades and Downgrades
Several research firms recently issued reports on ASPI. Wall Street Zen upgraded ASP Isotopes from a "strong sell" rating to a "sell" rating in a research note on Saturday, August 22nd. Weiss Ratings reiterated a "sell (d-)" rating on shares of ASP Isotopes in a research report on Wednesday, June 24th. Two analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus target price of $13.00.
Read Our Latest Research Report on ASP Isotopes
Institutional Trading of ASP Isotopes
A number of institutional investors have recently bought and sold shares of the business. WINTON GROUP Ltd bought a new position in shares of ASP Isotopes during the second quarter worth approximately $588,000. Integrated Wealth Concepts LLC acquired a new stake in shares of ASP Isotopes in the second quarter valued at approximately $176,000. Squarepoint Ops LLC boosted its stake in shares of ASP Isotopes by 75.6% in the second quarter. Squarepoint Ops LLC now owns 123,951 shares of the company's stock valued at $771,000 after buying an additional 53,354 shares during the period. Amundi bought a new stake in shares of ASP Isotopes in the second quarter valued at approximately $107,000. Finally, California State Teachers Retirement System boosted its stake in shares of ASP Isotopes by 864.2% in the second quarter. California State Teachers Retirement System now owns 754,131 shares of the company's stock valued at $4,691,000 after buying an additional 675,919 shares during the period. Institutional investors own 16.80% of the company's stock.
About ASP Isotopes
(
Get Free Report)
ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
